Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.

Muller MP, Dresser L, Raboud J, McGeer A, Rea E, Richardson SE, Mazzulli T, Loeb M, Louie M; Canadian SARS Research Network.

Pharmacotherapy. 2007 Apr;27(4):494-503.

PMID:
17381375
2.

Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.

Knowles SR, Phillips EJ, Dresser L, Matukas L.

Clin Infect Dis. 2003 Oct 15;37(8):1139-42. Epub 2003 Sep 12.

PMID:
14523782
3.

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children.

Gavin PJ, Katz BZ.

Pediatrics. 2002 Jul;110(1 Pt 1):e9. Review.

PMID:
12093990
4.

Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.

Bitnun A, Allen U, Heurter H, King SM, Opavsky MA, Ford-Jones EL, Matlow A, Kitai I, Tellier R, Richardson S, Manson D, Babyn P, Read S; Other Members of the Hospital for Sick Children SARS Investigation Team.

Pediatrics. 2003 Oct;112(4):e261.

PMID:
14523209
5.

Pharmacologic treatment of SARS: current knowledge and recommendations.

Tai DY.

Ann Acad Med Singapore. 2007 Jun;36(6):438-43.

6.

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.

Leong HN, Ang B, Earnest A, Teoh C, Xu W, Leo YS.

Trop Med Int Health. 2004 Aug;9(8):923-7.

7.

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.

Auyeung TW, Lee JS, Lai WK, Choi CH, Lee HK, Lee JS, Li PC, Lok KH, Ng YY, Wong WM, Yeung YM.

J Infect. 2005 Aug;51(2):98-102.

PMID:
16038758
8.

Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.

Chiou HE, Liu CL, Buttrey MJ, Kuo HP, Liu HW, Kuo HT, Lu YT.

Chest. 2005 Jul;128(1):263-72.

PMID:
16002945
9.

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, Ng MH, Chan P, Cheng G, Sung JJ.

Clin Microbiol Infect. 2004 Jul;10(7):676-8.

10.

Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.

Lau EH, Cowling BJ, Muller MP, Ho LM, Tsang T, Lo SV, Louie M, Leung GM.

Am J Med. 2009 Dec;122(12):1150.e11-21. doi: 10.1016/j.amjmed.2009.07.018.

PMID:
19958895
11.

Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome.

Chan MH, Wong VW, Wong CK, Chan PK, Chu CM, Hui DS, Suen MW, Sung JJ, Chung SS, Lam CW.

J Intern Med. 2004 Apr;255(4):512-8.

12.

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.

Pediatr Infect Dis J. 2007 Dec;26(12):1089-93.

PMID:
18043443
13.

The war against an unknown pathogen: rising to the SARS challenge.

[No authors listed]

Can Commun Dis Rep. 2003 May 1;29(9):77-82. English, French. No abstract available.

14.

Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.

Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ; Collaborative Antiviral Study Group.

Clin Infect Dis. 2004 Nov 1;39(9):1307-13. Epub 2004 Oct 11.

PMID:
15494907
15.

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.

Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plit ML, Carter IW, Malouf MA.

J Heart Lung Transplant. 2005 Dec;24(12):2114-9. Epub 2005 Sep 6.

PMID:
16364859
17.

SARS: pharmacotherapy.

Tsang K, Zhong NS.

Respirology. 2003 Nov;8 Suppl:S25-30. Review.

PMID:
15018130
18.

Current concepts in SARS treatment.

Fujii T, Nakamura T, Iwamoto A.

J Infect Chemother. 2004 Feb;10(1):1-7. Review.

PMID:
14991510
19.

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS.

JAMA. 2003 Jun 4;289(21):2801-9. Epub 2003 May 6. Erratum in: JAMA. 2003 Jul 16;290(3):334.

PMID:
12734147
20.

Infants born to mothers with severe acute respiratory syndrome.

Shek CC, Ng PC, Fung GP, Cheng FW, Chan PK, Peiris MJ, Lee KH, Wong SF, Cheung HM, Li AM, Hon EK, Yeung CK, Chow CB, Tam JS, Chiu MC, Fok TF.

Pediatrics. 2003 Oct;112(4):e254.

PMID:
14523207

Supplemental Content

Support Center